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Using an orthogonal tRNA-synthetase pair, unnatural amino acids can be genetically encoded with high effi-
ciency and fidelity, and over 40 unnatural amino acids have been site-specifically incorporated into proteins
in Escherichia coli, yeast, or mammalian cells. Novel chemical or physical properties embodied in these
amino acids enable new means for tailored manipulation of proteins. This review summarizes the method-
ology and recent progress in expanding this technology to eukaryotic cells. Applications of genetically en-
coded unnatural amino acids are highlighted with reports on labeling andmodifying proteins, probing protein
structure and function, identifying and regulating protein activity, and generating proteins with new proper-
ties. Genetic incorporation of unnatural amino acids provides a powerful method for investigating a wide
variety of biological processes both in vitro and in vivo.Introduction
The genetic code consists of 64 triplet codons specifying
20 canonical amino acids and 3 stop signals. This code is
preserved in all three kingdoms of life with few reassignments
(Knight et al., 2001). Although various amino acid derivatives
have been identified in natural proteins, most of them are post-
translational modifications of the canonical amino acids (Uy
and Wold, 1977). Two additional amino acids, selenocysteine
(Bock et al., 1991) and pyrrolysine (Srinivasan et al., 2002), are
also found to be incorporated into proteins cotranslationally
and are thus regarded as natural expansions of the genetic
code (Ambrogelly et al., 2006). With these amino acids and
with the help of posttranslational modifications and cofactors,
proteins are able to carry out various functions for sustaining life.
Given the important roles of proteins in biology, it is desirable
to be able tomanipulate proteins at will for understanding protein
structure-function relationships, investigating protein-involved
biological processes, and generating proteins and organisms
with new properties. Therefore, tremendous efforts have been
made regarding the incorporation of unnatural amino acids into
proteins to introduce new functional groups apart from those
found in the canonical amino acids, through chemical or biosyn-
thetic means (Wang and Schultz, 2004). Chemical methods use
chemistry to directly modify or prepare proteins. Early efforts
focused on derivatizing reactive side chains of the protein,
such as the thiol group of cysteine and the 3-amino group of
lysine (Kaiser et al., 1985). The advance of stepwise solid-phase
peptide synthesis makes possible the complete synthesis of
peptides and small proteins (usually < 100 residues) containing
any synthetically accessible unnatural amino acid (Kent, 1988).
The protein size limitation is subsequently overcome by semi-
synthetic protein ligation methods, in which two or more peptide
fragments are chemically ligated to make the full-length protein
(Dawson et al., 1994; Muir, 2003). By contrast, biosynthetic
methods harness the endogenous cellular machinery to translate
the target protein, in which the unnatural amino acid is incorpo-
rated cotranslationally. Bacterial strains auxotrophic for a
particular amino acid have been used to globally replace the
amino acid with a close structural analog (Cohen and Cowie,Chemistry & Bio1957; Minks et al., 2000; Link et al., 2003). For the site-specific
incorporation of unnatural amino acids, a suppressor tRNA is
chemically acylated with an unnatural amino acid. When added
into cell extracts or Xenopus oocytes that support protein trans-
lation, the acylated tRNA incorporates the attached unnatural
amino acid in response to a stop or extended codon (Noren
et al., 1989; Bain et al., 1989; Nowak et al., 1995). All of these
methods have proved to be extremely valuable, but each has
limitations in the lack of site selectivity, the in vitro nature of the
method, or the low incorporation efficiency (Wang and Schultz,
2004).
The ability to genetically encode unnatural amino acids in the
same manner as the canonical amino acids would enable
specific changes to be precisely made in proteins directly
in vivo, thus providing novel tools for understanding biology in
molecular terms in the native settings. Here, we review themeth-
odology for genetically incorporating unnatural amino acids into
proteins in live cells, and focus on recent advances in expanding
the method to eukaryotic cells. Representative applications are
discussed to illustrate the utility and scope of this technology
in studying various biological questions.
Methodology
Similar to canonical amino acids, the genetic encoding of an
unnatural amino acid requires a dedicated set of components
including a tRNA, a codon, and an aminoacyl-tRNA synthetase
(hereafter referred to as synthetase) (Figure 1) (Wang and
Schultz, 2002). This tRNA/codon/synthetase set, termed the
orthogonal set, must not crosstalk with endogenous tRNA/
codon/synthetase sets and must be functionally compatible
with other components of the translation apparatus. Specifically,
the orthogonal tRNA should not be recognized by any endoge-
nous synthetase, and it should decode the orthogonal codon,
which is not assigned to any canonical amino acid. The orthog-
onal synthetase should not charge any endogenous tRNA but
the orthogonal tRNA, and it should charge the orthogonal
tRNA with the unnatural amino acid only. The unnatural amino
acid cannot be a substrate for any endogenous synthetase
and must be available in the cytoplasm of the host cell. Once
expressed in cells, the orthogonal synthetase charges thelogy 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 323
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acylated tRNA incorporates the attached unnatural amino acid
into proteins in response to the unique codon by utilizing the
endogenous translational machinery. As all elements are genet-
ically encodable, this method has the potential to be applied to
almost all genetically tractable organisms.
Method Development in Escherichia coli
Escherichia coli was initially chosen as the host organism to
develop this general method for genetically encoding unnatural
amino acids in vivo, because its translational machinery had
been extensively studied and genetic manipulation of E. coli is
efficient and relatively straightforward. A unique codon is
required to specify the unnatural amino acid, and the amber
stop codon has been chosen for this purpose. There are three
stop codons that do not code for amino acids but function as
a signal for the termination of translation. By reassigning
a ‘‘blank’’ stop codon to an unnatural amino acid any overlap
and ambiguity with sense codons is avoided. The amber codon
became the ‘‘blank’’ codon of choice in this approach because (i)
it is the least used among the three stop codons in E. coli, and
because (ii) amber suppressor tRNAs have been identified or
engineered in E. coli to readthrough the amber codon with
canonical amino acids, and they do not significantly affect the
growth rates of E. coli cells (Normanly et al., 1990). Therefore,
specifying an unnatural amino acid with the amber codon was
expected to minimize perturbations to the genetic code and to
the health of the host.
Endogenous tRNAs and synthetases recognize their cognate
partners through delicate interactions between various regions324 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd All(Ibba and Soll, 2000). As there is already a pool of tRNA/synthe-
tase pairs inside cells, it is challenging to generate a new tRNA/
synthetase pair orthogonal to existing ones and functional in
translation. A successful strategy is to import a tRNA/synthetase
pair from a species in a different kingdom of life, followed by fine
tuning with selections. This strategy is based on early reports
showing that in vitro cross-species aminoacylation is often low
(Kwok and Wong, 1980). The first orthogonal tRNA/synthetase
pair in E. coli generated from archaeal bacteria was derived
from the tRNATyr/tyrosyl-tRNA synthetase (TyrRS) from Metha-
nococcus jannaschii (Wang et al., 2000). The anticodon of the
tRNA is mutated to CUA for recognizing the amber codon
UAG. This M. jannaschii tRNATyrCUA (MjtRNA
Tyr
CUA) and its cognate
MjTyrRS function efficiently in translation in E. coli, but there is
a small degree of aminoacylation of thisMjtRNATyrCUA by endoge-
nous E. coli synthetases. Tomake a completely orthogonal tRNA
whilemaintaining its affinity for the cognate synthetase, a general
strategy has been developed to evolve orthogonal tRNAs in
E. coli (Figure 2A) (Wang and Schultz, 2001). A library of tRNA
mutants is prepared by randomizing specific nucleotides, and
the orthogonal tRNA is selected by using a combination of nega-
tive and positive selection. The negative selection removes
nonorthogonal tRNAs from the library, and the subsequent posi-
tive selection removes nonfunctional tRNAs but allows only
orthogonal tRNAs with high affinity for the cognate synthetase
to pass. This approach was applied to the MjtRNATyrCUA, and the
mutRNATyrCUA that is orthogonal in E. coli and functions
efficiently with MjTyrRS to translate the amber codon was
identified.rights reserved
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orthogonal MjTyrRS from tyrosine to a desired unnatural amino
acid, which is also achieved by using two-step selections
(Figure 2B). A mutant synthetase library (>109 members) is
generated by randomizing five amino acid residues in the active
site of theMjTyrRS. The selection of the residues to be random-
ized was enabled by the availability of the Bacillus steraothermo-
philus TyrRS crystal structure (Brick et al., 1989). The library is
first positively selected in the presence of the unnatural amino
acid, in which active synthetase mutants able to charge the
orthogonal mutRNATyrCUA with the unnatural amino acid or any
common amino acid are identified. The active synthetases
Figure 2. Double-Sieve Selection with a
Mutant Library for Evolving Orthogonal
tRNAs or Unnatural Amino Acid-Specific
Synthetases
(A) Evolving orthogonal tRNAs in E. coli. The nega-
tive selection uses a toxic barnase gene contain-
ing two TAG stop codons at permissive sites.
tRNAs nonorthogonal to E. coli synthetases will
be charged with amino acids and suppress the
TAG codons to produce a functional barnase,
which kills the cell. The positive selection uses
the b-lactamase gene containing a TAG codon at
a permissive site. tRNAs charged by the cognate
synthetase and functional in translation will
suppress the TAG codon and express active
b-lactamase, which enables cells to survive in
ampicillin. Cells containing nonfunctional tRNAs
will be killed by ampicillin.
(B) Evolving orthogonal synthetases to be specific
for an unnatural amino acid in E. coli. The positive
selection uses the chloramphenicol acetyl trans-
ferase (CAT) gene containing a permissive TAG
stop codon in the presence of the unnatural amino
acid. Mutant synthetases capable of charging the
orthogonal mutRNATyrCUA with the unnatural or any
natural amino acid will express full-length CAT,
enabling cells to survive in chloramphenicol
(Cm). The negative selection uses the barnase
gene containing permissive TAG codons. Synthe-
tase mutants active toward natural amino acids
will charge the mutRNATyrCUA to suppress TAG
codons in the barnase gene, leading to cell death.
In the absence of the unnatural amino acid,
synthetase mutants specific for the unnatural
amino acid will survive the negative selection. To
improve activity and specificity, initial synthetase
gene hits can be recombined by using DNA shuf-
fling and are subject to the next round of selection.
are then subjected to a negative se-
lection, in which synthetase mutants
charging a common amino acid are elim-
inated. In the end, only synthetase
mutants specific for the unnatural amino
acid will survive both selections. Using
this approach, a mutant synthetase
specific for the unnatural amino acid
o-methyltyrosine (1, Figure 3) was identi-
fied from the MjTyrRS library. Together
with the evolved orthogonal mutRNATyrCUA
described above, it enables the site-
specific incorporation of o-methyltyro-
sine into proteins in response to the
amber codon in E. coli. Western blot and mass spectrometric
analyses of the expressed protein indicate that the translation
fidelity for o-methyltyrosine is close to that of common amino
acids (Wang et al., 2001).
This work represents the first expansion of the genetic code to
include an unnatural amino acid by using engineering
approaches. Structurally similar to tyrosine and phenylalanine,
o-methyltyrosine provides an excellent case to demonstrate the
high translational fidelity that can be achieved by using this
approach. Meanwhile, it was important to test whether this
method could be generally used to genetically encode various
unnatural amino acids, especially those significantly deviatingChemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 325
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showed that L-3-(2-naphthyl)alanine (2), which represents a signif-
icant structuralperturbation relative to tyrosine, canalsobegenet-
ically incorporated into proteins in E. coli with high efficiency and
fidelity (Wang et al., 2002). In the following years, the principle and
methodsdevelopedhereinhavebeenused togenetically incorpo-
rate more than 40 different unnatural amino acids in E. coli (Wang
et al., 2006b). For more than 80%of unnatural amino acids incor-
porated, the orthogonal tRNA is the same mutRNATyrCUA, and the
orthogonal synthetases are all evolved from the MjTyrRS (Wang
et al., 2001), suggesting the great flexibility of the active site of
TyrRS to be modified to accommodate different substrates.
Suppression efficiencies of most unnatural amino acids range
from25%to75%of thewild-typeprotein, and translational fidelity
is>99%. Yields of unnatural amino acid-containing proteins are in
the range of several milligrams to tens ofmilligrams per liter of cell
culture. Additional orthogonal tRNA/synthetase pairs have since
been generated (Anderson and Schultz, 2003), and four-base
codons have also been used to encode unnatural amino acids in
E. coli (Anderson et al., 2004). In addition, a biosynthetic pathway
forp-aminophenylalaninewascreated inE.coli so that thestrain is
able to produce and genetically incorporate p-aminophenylala-
nine autonomously (Mehl et al., 2003).
Transition to Yeast
There are examples of eukaryotic organisms having natural
changes in their genetic codes (Knight et al., 2001), suggesting
Figure 3. Structures for Unnatural Amino
Acids Discussed in the Text
that it is possible to artificially alter the
genetic code in eukaryotes as well. The
general strategy developed to genetically
encode unnatural amino acids in E. coli
should also be applicable to eukaryotic
organisms. A number of tRNA/synthetase
pairs derived from E. coli have been
shown to be orthogonal in eukaryotic
cells (Drabkin et al., 1996; Kowal et al.,
2001), again due to the low crosskingdom
aminoacylation. In particular, the E. coli
tRNATyrCUA/TyrRS pair is orthogonal in
yeast (Edwards and Schimmel, 1990;
Kwok and Wong, 1980). Moreover, the
success in evolving theMjTyrRS to incor-
porate a wide range of unnatural amino
acids in E. coli guided use of the E. coli
tRNATyrCUA/TyrRS pair in yeast.
To evolve synthetases specific for
unnatural amino acids in yeast, a general
selection scheme analogous to that used
in E. coli was set up, which also uses
positive and negative selections with
a mutant synthetase library. A synthetase
library (108 in size) is similarly constructed
by randomizing five active site residues in
the E. coli TyrRS that correspond to the
five residues randomized in the MjTyrRS
(Wang et al., 2001). Mutant synthetases are identified after
several rounds of selection that, together with the E. coli
tRNATyrCUA, incorporate a number of unnatural amino acids into
proteins in yeast, albeitwith rather lowprotein yields (0.05mg/L)
(Chin et al., 2003).
Low incorporation efficiency results in reduced yield of the full-
length protein containing the unnatural amino acid and in an
increase of truncated protein products terminated at the intro-
duced amber codon, thus creating difficulties with employing
genetically encoded unnatural amino acids in yeast. To address
this problem, new methods have been developed to efficiently
express orthogonal prokaryotic tRNAs and to improve the target
mRNA stability in yeast. Transcription and processing of tRNAs
are different in prokaryotes and eukaryotes. A major distinction
is that E. coli tRNAs are transcribed through promoters upstream
of the tRNA gene, whereas eukaryotic tRNAs are transcribed
through promoter elements within the tRNA known as the A-
and B-box (Figure 4A ) (Galli et al., 1981). The A- and B-box iden-
tity elements are conserved among eukaryotic tRNAs but are
absent in many E. coli tRNAs. Creating the consensus A- and
B-box sequences in E. coli tRNAs throughmutation could cripple
the tRNA (Sakamoto et al., 2002). The E. coli tRNATyrCUA has the
B-box but no fully matched A-box. In the previously described
system (Chin et al., 2003), only the tRNA structural gene was in-
serted in a plasmid, resulting in a basal level of tRNA expression
likely driven by a cryptic promoter elsewhere (Chen et al., 2007).326 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved
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and 30-flanking sequences of an endogenous yeast suppressor,
tRNATyrCUA (SUP4) (Francis and RajBhandary, 1990; Drabkin et al.,
1996; Kowal et al., 2001; Chen et al., 2007). The E. coli tRNATyrCUA
without the -CCA trinucleotide is flanked by these sequences,
and this cassette is repeated in tandem 3–6 times. A strong
PGK1 RNA Polymerase II promoter is additionally placed
upstream of the tandem arrangements (Chen et al., 2007). This
combination gives an overall > 50 fold increase in tRNA levels
compared to the previous tRNA alone scheme. Together with
optimized expression of the synthetase, this approach improves
the yield of unnatural amino acid-containing proteins to 6–8mg/L
yeast cells. A new method to efficiently express prokaryotic
tRNAs in yeast involves an external promoter containing the
consensus eukaryotic A- and B-box sequences (Figure 4B)
(Wang and Wang, 2008). The promoter is placed upstream of
the E. coli tRNA (without 30-CCA) to drive the transcription of
a primary RNA consisting of the promoter and the tRNA. The
promoter is cleaved posttranscriptionally to yield the mature
tRNA. Two yeast Pol III promoters, the RPR1 promoter and the
SNR52 promoter, have been shown to efficiently drive the
expression of the E. coli tRNATyrCUA in yeast. The expressed
E. coli tRNATyrCUA is 6- to 9-fold more active in translation than the
same tRNA transcribed by using the SUP4 50-flanking sequence.
Interestingly, the increased activity is not a result of a higher
tRNA transcription level, suggesting the importance of proper
tRNA processing. The cleavage of the SNR52 or RPR1 promoter
from the primary RNA transcript could directly generate the
correct 50 end of the tRNA. This external promoter method has
also been used to express E. coli tRNALeuCUA in yeast, which func-
tions efficiently in translation as well, suggesting that it can be a
general method for functionally expressing different prokaryotic
tRNAs in yeast.
An important factor for unnatural amino acid incorporation in
eukaryotes is the stability of the target mRNA. Eukaryotic cells
have an mRNA surveillance mechanism, nonsense-mediated
mRNA decay (NMD), to identify mRNAs containing premature
stop codons and target the mRNA for rapid degradation (Amrani
et al., 2006). The amber stop codon is thus far the most
frequently used codon to encode unnatural amino acids, but
NMD could shorten the target mRNA lifetime, resulting in a lower
protein yield. Inactivation of NMD would preserve the stability of
the UAG-containing mRNA and thus enhance the incorporation
efficiency. An NMD-deficient yeast strain was generated by
knocking out the UPF1 gene, an essential component for
NMD. The unnatural amino acid incorporation efficiency was
indeed increased more than 2-fold in the upf1D strain compared
to the wild-type yeast (Wang and Wang, 2008). NMD in yeast
shows a polar effect of nonsense codon positions (Cao and
Parker, 2003). The steady-state mRNA level is reduced by
NMD more significantly when the nonsense codon is closer to
the 50 end than to the 30 end of an mRNA. Consistently, the
increase of unnatural amino acid incorporation efficiency in the
upf1D strain correlates with the position of the UAG codon:
more than a 2-fold increase is measured when the amber codon
is within the N-terminal two thirds of the gene, whereas no signif-
icant increase is detected when it is within the C-terminal fourth
of the coding region (Q.W. and L.W., unpublished data). By using
the external SNR52 promoter and the NMD-deficient upf1D
strain, the overall yields of purified unnatural amino acid-contain-
ing proteins have reached 15 mg/L yeast cells, 300-fold
higher than the previous system and comparable to the yield in
E. coli.
Transition to Mammalian Cells
Genetic incorporation of unnatural amino acids into proteins in
mammalian cells face the same challenges as in yeast. Specifi-
cally, a major challenge is how to efficiently express prokaryotic
orthogonal tRNAs and to ensure they are translationally compe-
tent in mammalian cells, due to the aforementioned difference in
tRNA transcription and processing. In addition, another major
challenge is how to evolve mutant orthogonal synthetases to
be specific for an unnatural amino acid for use in mammalian
cells. The latter arises because the transfection efficiency of
mammalian cells is much lower than the transformation effi-
ciency of E. coli or yeast, making it impractical to generate large
synthetase mutant libraries inside mammalian cells. Moreover,
survival-death selection in mammalian cells is not as effective
as in E. coli and yeast. Therefore, it is difficult to evolve a specific
Figure 4. General Methods for Efficient Expression of Prokaryotic
tRNAs in Eukaryotic Cells by Using Special Pol III Promoters
(A) Gene elements for tRNA transcription in E. coli and eukaryotic cells.
(B) Expression of prokaryotic tRNAs in yeast by using an external SNR52 or
RPR1 Pol III promoter, which contains the consensus A- and B-box sequences
and is posttranscriptionally cleaved from the primary transcript.
(C) A type-3 Pol III promoter, such as the H1 promoter, with a defined transcrip-
tion initiation site is used to express prokaryotic tRNAs in mammalian cells.Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 327
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mammalian cells.
The E. coli tRNATyrCUA/TyrRS pair is orthogonal in mammalian
cells, but the E. coli tRNATyrCUA is not easily expressed in mamma-
lian cells, presumably due to the lack of a matched A-box. Fortu-
nately, the B. stearothermophilus tRNATyrCUA happens to contain
consensus A- and B-box sequences, is not charged bymamma-
lian synthetases, and works with the heterologous E. coli TyrRS
in suppressing the TAG codon. The B. stearothermophilus
tRNATyrCUA (lacking 3
0-CCA) was linked to the 50-flanking sequence
of the human tRNATyr, and nine tandem repeats of this gene
arrangement were used for tRNA expression (Sakamoto et al.,
2002). A small collection of designed active-site variants of the
E. coli TyrRS was screened in vitro, and a mutant synthetase
using 3-iodotyrosine (3) more effectively than Tyr is identified.
This mutant synthetase is used with nine tandem B. stearother-
mophilus tRNATyrCUA to incorporate 3-iodotyrosine into proteins
in Chinese hamster ovary (CHO) cells and HEK293 cells with
95% fidelity (Sakamoto et al., 2002). In another attempt, muta-
tions were introduced into the A-box region of theB. subtilis tryp-
tophan opal suppressor tRNA (tRNATrpUCA) to create a consensus
A-box (Zhang et al., 2004a). The 30-CCA-lacking mutant tRNA
was expressed by using the 50- and 30-flanking sequences
from the Arabidopsis tRNATrp. Together with a rationally de-
signed B. subtilis TrpRS mutant, this tRNA incorporates
5-hydroxytryptophan (4) into the foldon protein in HEK293 cells
in response to the opal stop codon with 97% fidelity.
Encouraging as these results are, it remained a challenge to
incorporate various unnatural amino acids in mammalian
cells with high efficiency and fidelity. The above-described
approaches may not be generally applicable to other tRNA/
synthetase pairs or other unnatural amino acids. As for tRNA
expression, most bacterial tRNAs do not have the consensus
eukaryotic A- and B-box sequences, and heterologous pairing
of the tRNA with synthetase often results in low activity. Since
theA- andB-box lie at nucleotides involved in tertiary interactions
that support the L-shaped tRNA structure, mutations to create
such consensus sequences, although they may not dramatically
decrease the activity of theB. subtilis tRNATrpUCA, greatly impair the
suppression ability of theE. coli tRNATyrCUA (Sakamoto et al., 2002).
In addition, using tandem repeats to boost the tRNA expression
levelmay eventually lead to lower expression, especially in stable
cell lines, as repeating sequences are frequently associated with
gene silencing (Hsieh and Fire, 2000).
A new method has been developed that involves the use of an
external type-3 Pol III promoter to efficiently express functional
prokaryotic tRNAs in mammalian cells (Figure 4C) (Wang et al.,
2007b). A type-3 Pol III promoter has its promoter elements
exclusively upstream of the coding sequence and does not
require any intragenic elements (such as the A- and B-box) for
transcription (Willis, 1993). Therefore, tRNAs with or without
the consensus A- and B-box sequences are both expected to
be transcribed by this type of promoter in mammalian cells. In
addition, the transcription initiation site of some type-3 Pol III
promoters, such as the H1 promoter (Myslinski et al., 2001)
and the U6 small-nuclear RNA promoter (Paule and White,
2000), is well defined, which could be used to generate the
correct 50 end of the tRNA without further posttranscriptional
processing. Using a fluorescence-based translation assay,328 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd AlltRNA expression elements including the promoter, the 50- and
30-flanking sequences, and the 30-CCA trinucleotide are linked
to the E. coli tRNATyrCUA in various combinations and are system-
atically tested for their ability to generate functional tRNAs in
mammalian cells. The gene arrangement that yields tRNAs
with the highest translational activity is the H1 promoter followed
by the E. coli tRNATyrCUA (without 3
0-CCA) and then by the 30-flank-
ing sequence of tRNAfMet. E. coli tRNATyrCUA expressed by using
this method is 70-fold more active in translation than the one
expressed with the 50- and 30-flanking sequences of human
tRNAfMet. This method has also been used to express different
E. coli tRNAs successfully, and it is effective in various mamma-
lian cells such as HEK293 cells, HeLa cells, and primary neurons.
For generating unnatural amino acid-specific synthetase
mutants, it is difficult to predict a priori which active site residues
need to be mutated. More often, mutations at multiple sites are
required to achieve high substrate specificity, suggesting that
small collections of synthetase mutants will likely fall short.
Mutants thus generated may still recognize common amino
acids, as is the case with the synthetase used to incorporate
3-iodotyrosine.
To circumvent the challenge of evolving unnatural amino
acid-specific synthetases directly in mammalian cells, a transfer
strategy is used. Since the E. coli tRNATyrCUA/TyrRS pair is orthog-
onal in mammalian cells as well as in yeast, and the translational
machinery of yeast is homologous to that of higher eukaryotes, it
should be possible to evolve the specificity of this synthetase
in yeast and transfer the optimized tRNA/synthetase pairs for
use in mammalian cells. In one report, mutant synthetases that
were evolved in yeast from the E. coli TyrRS specific for different
unnatural amino acids (Deiters et al., 2003; Chin et al., 2003),
together with the B. stearothermophilus tRNATyrCUA, have been
successfully used in CHO cells and HEK293 cells for incorpo-
rating the corresponding unnatural amino acids (Liu et al.,
2007). A high translational fidelity for the unnatural amino acid
is confirmed with mass spectrometric analysis, and proteins
could be produced up to 1 mg per 23 107 cells. In another report,
mutant synthetases evolved in yeast from the E. coli TyrRS are
used together with the cognate E. coli tRNATyrCUA expressed by
the H1 promoter in mammalian cells (Wang et al., 2007b).
Because the H1 promoter also enables the functional expression
of the E. coli tRNALeuCUA, mutant synthetases evolved in yeast from
the E. coli LeuRS (Summerer et al., 2006) are also successfully
transferred in mammalian cells to incorporate the fluorescent
unnatural amino acid dansylalanine (Wang et al., 2007b). Incor-
poration efficiencies are in the range of 13%–41%, depending
on the activity of the evolved synthetase. The incorporation
fidelity is also high, as measured by a sensitive fluorescence
assay based on the translation of GFP. Unnatural amino acids
have been incorporated in HEK293 cells, HeLa cells, and even
in primary neurons.
Applications
New chemical, physical, and biological properties can be intro-
duced into proteins via the incorporation of unnatural amino
acids, and thus unnatural amino acids have been exploited to
study a wide range of biological problems involving proteins. In
particular, the stability, specificity, and catalytic properties of
multiple proteins have been extensively studied with unnatural
amino acids incorporated with chemically acylated tRNAs,rights reserved
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tion (Cornish et al., 1995). Microinjection of chemically acylated
tRNAs into Xenopus oocytes enables studies of integral
membrane proteins with unnatural amino acids. Various ion
channels and neurotransmitter receptors have been probed
with unnatural amino acids by using electrophysiological tech-
niques, yielding novel insights into the function role of conserved
amino acid residues and the gating mechanism of this important
family of proteins (Beene et al., 2003; Lummis, et al., 2005).
Recent years have also seen elegant studies of signal transduc-
tion, selectivity of ion channels, and chromatin biology by using
unnatural amino acids that are introduced with native chemical
ligation or expressed protein ligation (Hahn et al., 2007; Valiya-
veetil et al., 2006; McGinty et al., 2008). There are already
many excellent reviews on different aspects of this subject
(Cornish et al., 1995; Hohsaka and Sisido, 2002; Beene et al.,
2003; Link et al., 2003; Wang and Schultz, 2004; Schwarzer
and Cole, 2005; Pellois and Muir, 2006), so here we will focus
on the applications of unnatural amino acids that are genetically
encoded by using the orthogonal tRNA/synthetase method.
Representative examples are summarized to illustrate the
usefulness of this technology in modifying and investigating
proteins, regulating protein functions, and generating new
protein properties. We note that some of the unnatural amino
acids discussed below have also been incorporated into
proteins by using other approaches, details of which can be
found in the reviews cited above.
Labeling and Modifying Proteins
Reactive side chains of canonical amino acids such as cysteine
and lysine have long been used for the selective chemical modi-
fication of proteins, but the intrinsic selectivity is low unless the
amino acid is absent or can be mutated in the target protein. A
nonproteinogenic chemical group embodied by an unnatural
amino acid can serve as a unique chemical handle for bio-
orthogonal chemical reactions, through which a variety of
reagents can be selectively appended to proteins in vitro. These
reagents can be biophysical probes, tags, posttranslational
modifications, and groups modifying protein stability or activity.
Currently, site-specific labeling of a target protein via unnatural
amino acids directly inside live cells is still challenging.
The keto group is not present in any of the canonical amino
acids, and it reacts with hydrazides, alkoxyamines, and semicar-
bazides under aqueous, mild conditions to respectively produce
hydrazone, oxime, and semicarbazone linkages that are stable
under physiological conditions. The keto group has been genet-
ically encoded in E. coli in the form of p-acetylphenylalanine (5)
and is specifically labeled in vitro with fluorescein hydrazide
and biotin hydrazide with greater than 90% yield (Wang et al.,
2003). Similarly, fluorescent dyes are selectively appended to
the m-acetylphenylalanine (6) introduced into the membrane
protein LamB in E. coli (Zhang et al., 2003). p-Acetylphenylala-
nine and p-benzoylphenylalanine (21) have also been incorpo-
rated into rhodopsin, a transmembrane G protein-coupled
receptor, in mammalian cells (Ye et al., 2008). The purified
mutant rhodopsin is labeled in vitro with fluorescein hydrazide.
Natural glycoproteins are often present as a population of
different glycoforms, which complicates glycan structure anal-
ysis and the study of glycosylation effects on protein structure
and function. Generation of pure glycoprotein mimetics withChemistry & Biodefined glycan structures will be valuable for the systematic
understanding of glycan function and the development of
improved glycoprotein therapeutics. To prepare homogenous
glycoprotein mimetics, sugars are synthesized in the aminooxy
form and are attached to p-acetylphenylalanine incorporated
at defined sites in proteins (Figure 5A) (Liu et al., 2003). The
attached sugar is subsequently elaborated by adding additional
saccharides with glycosyltransferases to generate oligosaccha-
rides with defined structures. Alternatively, an aminooxy-derivat-
ized glycan can also be covalently coupled to the p-acetylpheny-
lalanine-containing protein in one step.
PEGylation, the attachment of polyethylene glycol (PEG) to
proteins, increases protein stability and solubility. In comparison
with using common amino acids, PEGylation using a unique
chemical handle of an unnatural amino acid increases the homo-
geneity of the final protein product and provides flexibility in
choosing PEGylation sites for optimizing protein activity. PEG
has been attached to p-acetylphenylalanine introduced in the
human growth hormone to afford a protein that retained wild-
type activity but had a considerably improved half-life in serum
(P.G. Schultz, personal communication). This approach can be
extended to other therapeutic proteins to generate purer and
more stable protein drugs.
Azide and acetylene are two additional nonproteinogenic
chemical groups that react with each other through a copper
(I)-catalyzed [2+3] cycloaddition reaction. p-Azidophenylalanine
(7) and p-propargyloxyphenylalanine (8) have been genetically
incorporated into human superoxide dismutase-1 in E. coli and
yeast (Deiters et al., 2003, 2004). Purified mutant proteins are
labeled in vitro with fluorescent dyes or PEG derivatized with
the complementary functional group (Figure 5B). The require-
ment of Cu+ as a catalyst maymake it difficult to use this reaction
inside live cells. The azide group can also react with phosphine
derivatives through the Staudinger ligation. p-Azidophenylala-
nine has been incorporated into the Z-domain protein in E. coli
or into peptides displayed on phage, and it can be labeled with
fluorescein-derived phosphines (Figure 5B) (Tsao et al., 2005).
Phenylselenide undergoes oxidative elimination in hydrogen
peroxide followed by a Michael addition with thiols (Figure 5C).
Phenylselenocysteine (9) is genetically incorporated into GFP
in E. coli (Wang et al., 2007a). After treating with hydrogen
peroxide, the resultant dehydroalanine is selectively labeled
in vitro with thiol-containing mannopyranose to generate an
analog of glycosylated GFP, or with n-hexadecylmercaptan to
generate a palmitoylated GFP with a nonhydrolyzable linkage.
Similarly, phenylselenocysteine has been used to append
analogs of methyl- or acetyl-lysine onto the purified Xenopus
histone H3, important histone modifications that contribute to
chromatin structure and accessibility (Guo et al., 2008). The H3
protein with an acetyl-lysine 9 mimic is deactylated by a histone
deacetylation complex and phosphorylated by Aurora B kinase,
suggesting that such chemically labeled histones are likely func-
tional in nucleosomes to facilitate the analysis of chromatin.
Besides using a chemical handle, changes can be directly
incorporated into proteins in the form of unnatural amino acids,
in particular, to mimic posttranslational modifications. These
modifications are common in eukaryotic proteins playing impor-
tant roles in protein stability, localization, and function, but they
cannot be easily produced in bacterial cells. It is also difficultlogy 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 329
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cells. Unnatural amino acids with the properties of posttransla-
tional modifications may allow for the generation of homogenous
proteins with the desired modifications to uncover their func-
tional roles and possibly to control protein function.
Glycosylation is a frequent modification of eukaryotic proteins.
Homogeneous glycoprotein mimetics with defined glycan struc-
tures can be prepared by using the keto- or phenylselenide-
containing unnatural amino acids, but it leaves a small unnatural
linkage between the protein and the first sugar. This linkage does
not prevent glycosyltransferases from attaching additional
sugars (Liu et al., 2003), but whether it affects other glycoprotein
functions awaits more research. To prepare a native glycosy-
lated protein, mutant synthetases have been evolved that site-
specifically incorporate b-N-acetylglucosamine-O-serine (10)
or N-acetylgalactosamine-a-O-threonine (11) into proteins in
E. coli (Zhang et al., 2004b; Xu et al., 2004). Since there is no
Figure 5. Protein Labeling and Modification
through Genetically Incorporated Chemical
Handles
(A) A general method for preparing glycoprotein
mimetics with defined glycan structure by using
the keto group.
(B) Protein modification with PEG through
a copper-catalyzed cycloaddition reaction (top)
and with fluorescein through Staudinger ligation
(bottom).
(C) Protein modification through phenylselenocys-
teine.
endogenous glycosyl modification in
E. coli, genetic incorporation of glycosy-
lated amino acids will help improve the
production of proteins that require glyco-
sylation for proper folding and function.
Phosphorylation of serine, threonine,
and tyrosine by kinases and reversion
by phosphatases are key switches in
various signal transduction cascades. A
phosphorylation mimic resistant to phos-
phatase activity can be used to identify
the role of a specific phosphorylated
residue, and to create stably activated
proteins for functional assays. p-Carbox-
ymethylphenylalanine (pCMF, 12), a non-
hydrolyzable analog of phosphotyrosine,
was found to be capable of mimicking
the phosphorylated state of Tyr (Xie
et al., 2007b). Wild-type human STAT1,
after being phosphorylated at Tyr701,
forms a homodimer and strongly binds
a DNA duplex. The mutant STAT1 with
Tyr701 substituted with pCMF also binds
the same DNA duplex tightly, suggesting
that pCMF could replace phosphotyro-
sine in the generation of constitutively
active phosphoproteins.
Acetylation is another important
reversible protein modification. For
instance, acetylation of lysine residues in histone proteins
controls the secondary structure of chromatin as well as gene
expression levels. One method for generating acetyl- and
methyl-lysine analog-tagged histones is described above and
uses phenylselenocysteine. N3-acetyllysine (13) is genetically
incorporated into proteins in E. coli (Neumann et al., 2008). In the
presence of a deacetylase inhibitor, manganese superoxide dis-
mutase containing N3-acetyllysine at residue Lys44 is produced;
however, acetylation of Lys44 does not appear to affect the
enzyme activity. In addition, N3-acetyllysine and other lysine
analogs are also incorporated into GRB2 in HEK293 cells (Mukai
et al., 2008).
Probing Protein Structure and Function
The structure and function relationship of proteins can be
studied with greater precision and accuracy when various
biophysical probes are site-specifically incorporated into pro-
teins. Genetically encoded biophysical probes further extend330 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved
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ment of proteins.
NMR spectra from large proteins or complexes are
complicated to interpret. Specific NMR labels introduced at
defined locations in a protein would greatly reduce complexity
and simplify signal assignment. Tri-fluoromethylphenylalanine
(tfm-Phe, 14) was incorporated at the binding interface of two
obligate dimers, nitroreductase and histidinol dehydrogenase,
both of which contain active sites at the dimer interface (Jackson
et al., 2007). Substrate- or inhibitor-induced conformational
changes are evident by monitoring the 19F NMR chemical shifts.
In another report, the binding of a small-molecule ligand to the
thioesterase domain of fatty acid synthase was studied by
NMR by using tfm-Phe, 13C- and 15N-labeled o-methyltyrosine
(15), and 15N-labeled o-nitrobenzyltyrosine (16) at 11 different
sites (Cellitti et al., 2008). Comparing the spectra of different
mutants and the conformational changes upon addition of the
small molecule, the binding site of this molecule is mapped on
the protein. It is also worthy to note that photo-decaging of 16
to regenerate 15N-labeled tyrosine provides a useful method
of isotopic labeling of selected tyrosines without structural
change.
p-Cyanophenylalanine (pCNPhe, 17) is a probe for infrared (IR)
spectroscopy (Schultz et al., 2006). The stretching vibration of its
nitrile group has strong absorption and a frequency (nCN) at
2200 cm1, which falls in the transparent window of protein
IR spectra. pCNPhe was incorporated into myoglobin at His64,
a site close to the iron center of the heme group, to examine
ligand-bound states of the heme group. When the Fe(III) ligand
is changed from water to cyanide in ferric myoglobin, nCN shifts
from 2248 cm1 to 2236 cm1. In the ferrous myoglobin, the
linear Fe(II)CO complex shows a nCN absorption at 2239 cm
1,
whereas the bent Fe(II)NO and Fe(II)O2 complexes show absorp-
tion at 2230 cm1. These results demonstrate that the nitrile
group is a sensitive probe for ligand binding and local electronic
environment.
Fluorescent unnatural amino acids may complement the
widely used fluorescent proteins in imaging protein expression,
dynamics, and function. Their smaller size canminimize potential
perturbations to target proteins, and their fluorophores can be
designed to report different microenvironmental changes. Dan-
sylalanine (18) contains the dansyl fluorophore, whose fluores-
cence intensity increases in hydrophobic surroundings. When
incorporated on the surface of a b barrel in human superoxide
dismutase, dansylalanine shows little change in fluorescence
after protein denaturation; when placed at an internal site of
the b barrel, its emission wavelength is red shifted and intensity
is greatly decreased upon denaturation (Summerer et al., 2006).
Therefore, fluorescence change can be used to infer when
a residue is exposed to solvent during unfolding. L-(7-hydroxy-
coumarin-4-yl) ethylglycine (19) bears the coumarin fluorophore,
which is sensitive to pH and polarity. It was genetically incorpo-
rated into myoglobin at two different helices, A or C (Wang et al.,
2006a). At 3 M urea, coumarin placed in helices A and C shows
a similar increase in fluorescence. However, at 2 M urea, fluores-
cence increases only when coumarin is incorporated in helix A,
suggesting that helix C is not destabilized until urea concentra-
tions reach above 3 M. This result is consistent with previous
NMR data, and it suggests that coumarin fluorescence canChemistry & Bioalso report local protein unfolding. Another reporter, p-nitrophe-
nylalanine (20) quenches the fluorescence of nearby tryptophans
(Tsao et al., 2006). When it is incorporated in a leucine zipper
protein, GCN4, the tryptophanyl fluorescence is quenched in
a distance-dependent manner, making p-nitrophenylalanine a
useful distance probe to monitor protein folding or conforma-
tional changes. Although still in its infancy, the use of genetically
encoded fluorescent amino acids as real-time optical reporters
and biosensors in live cells is promising.
Introducing heavy atoms into protein crystals is a critical step
for phase determination in X-ray crystallography. A new method
to introduce heavy atoms into proteins is to genetically incorpo-
rate p-iodophenylalanine (3) into proteins in E. coli or yeast.
p-Iodophenylalanine was incorporated into the T4 lysozyme,
and the mutant protein was crystallized (Xie et al., 2004). Diffrac-
tion data were collected with a laboratory CuKa X-ray source,
and the structure was solved by using single-wavelength anom-
alous dispersion phasing. A single iodinated amino acid among
164 residues results in a strong anomalous signal, about 3% of
the total intensities, which compares favorably with the level
achieved with selenomethionine by using synchrotron beams.
p-Iodophenylalanine causes little structural perturbation when
substituted for Phe in the core of the T4 lysozyme. This approach
ensures that the heavy atom iodine is quantitatively introduced at
a specific site of the target protein. The strong anomalous signal,
the possibility of incorporation at multiple sites and in different
cell types, and the use of an in-house X-ray source should facil-
itate solving protein structures in a high-throughput manner.
The side chain size of unnatural amino acids can be conve-
niently altered at atomic precision to provide desired changes
for probing the bulk effects of amino acids on protein structure
and function. The fast inactivation mechanism of the voltage-
gated K+ channel Kv1.4 was examined by using unnatural amino
acids in HEK293 cells (Wang et al., 2007b). The classic ball-and-
chainmodel for channel inactivation proposes that theN-terminal
inactivation peptide forms a ball-like domain to occlude the
channel exit for ions. In contrast, a new model hypothesizes
that the inactivation peptide threads through a side portal and
extends into the inner pore to block ion flow. To experimentally
test this, Tyr19 in the inactivation peptide was initially mutated
to Phe or Trp, which shows no difference in channel inactivation.
However, mutation to o-methyltyrosine (1) results in a markedly
slower inactivation, as does mutation to dansylalanine (18)
(Figure 6). Modeling suggested that the diameter of the inactiva-
tion peptide, which is unchanged for Phe or Trp at this site but is
larger for o-methyltyrosine and dansylalanine, is important for
channel inactivation. This is likely due to the narrow width of the
side portal in the channel, supporting the new model for channel
inactivation.
Identifying and Regulating Protein Activity
The identification of protein interactions and the control of
protein activities in vivo would ideally require methods that are
noninvasive and easy to administer. Application of light is an
attractive approach. Photoresponsive unnatural amino acids
that can crosslink with nearby molecules, shed protecting
groups, or change conformation have been developed and
genetically incorporated into proteins. They enable the in vivo
manipulation of proteins, which should have great potential in
molecular and synthetic biology applications.logy 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 331
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protein interactions in cells. Site-specific photocrosslinking
enabled by genetically encoded unnatural amino acids may
help to pinpoint transient or weak interactions, to identify which
region is involved, and to distinguish direct from indirect interac-
tions. p-Azidophenylalanine (7), p-benzoylphenylalanine (pBpA,
21), and p-(3-trifluoromethyl-3H-diazirin-3-yl)phenylalanine
(TfmdPhe, 22) contain photocrosslinking side chains and have
been genetically incorporated into proteins (Chin et al., 2002a,
2002b; Tippmann et al., 2007). pBpA is incorporated into the
heat shock protein ClpB in E. coli at residue Tyr251, which is
considered as the main substrate recognition residue (Schlieker
et al., 2004). Biotinylated substrate peptides are shown to be
crosslinked upon UV light exposure, but not if pBpA is incorpo-
rated elsewhere. pBpA is also incorporated into Ste2p,
a GPCR that binds a short peptide pheromone a factor, at
several sites on the extracellular loops in yeast (Huang et al.,
2008). At two sites, biotinylated a factor is indeed photocaptured
and identified by western blot. pBpA has also been incorporated
into Grb2 (growth-factor-receptor-bound protein 2) in the ligand-
binding pocket of the SH2 domain in mammalian cells. When
activated epidermal growth factor receptor (EGFR) and pBpA
containing Grb2 are coexpressed and treated with UV light,
a larger-molecular weight band is detected, suggesting the
binding of EGFR to Grb2 (Hino et al., 2005). Genetically encoded
photocrosslinkers should provide high specificity and be
compatible with a wide range of biological processes, making
this strategy attractive for probing protein complexes and inter-
actions in vivo.
Photocaging of critical residues can be harnessed to regulate
protein activity by using light. A photoremovable protecting
group is installed onto the suitable amino acid in the target
protein, which masks the amino acid and renders the protein
inactive. Photolysis releases the caging group and converts
Figure 6. Unnatural Amino Acids to Probe
the Inactivation Mechanism of Ion Channel
Kv1.4
o-Methyltyrosine or dansylalanine extends the
side chain length of tyrosine, which impedes the
inactivation peptide from threading through
the side portal of the ion channel and abolishes
the fast inactivation, as shown in the current time
curve.
the amino acid to the wild-type active
form, generating abrupt or localized
changes. For example, mutation of the
active site Cys residue in the proapop-
totic protease caspase 3 to o-nitroben-
zylcysteine (23) in yeast leads to a catalyt-
ically inactive enzyme. UV illumination of
the cell lysate converts 40% of the
caged caspase to the active enzyme
(Wu et al., 2004). o-Nitrobenzyltyrosine
(24) is incorporated into b-galactosidase
at Tyr503 in E. coli, which effectively
reduced the activity of this enzyme to
5% of the wild-type form (Deiters et al.,
2006). After a 30 min exposure of bacterial cells to UV light, the
enzyme regains activity to 70% of wild-type levels. A photoc-
aged serine, 4,5-dimethoxy-2-nitrobenzylserine (DMNB-Ser,
25), is incorporated at phosphoserine sites in the transcription
factor Pho4 to control its phosphorylation in yeast (Lemke
et al., 2007). DMNB-Ser blocks phosphorylation until photolysed
with 405 nm light. Serine is then regenerated and subsequently
phosphorylated, triggering the nuclear export of Pho4 (Fig-
ure 7A). Photocaging prevents posttranslational modification of
the selected residue until a desired moment, which is a more
versatile method than mutating the residue to a null amino acid
in examining signal transductions.
Photolysis of a caged residue is an irreversible process.
Reversible modulation can be achieved with the photochromic
azobenzene group, which undergoes a reversible cis-trans isom-
erization by using lightwith differentwavelengths (Figure 7B). The
resultant change in geometry and/or dipole of the compound can
be used to regulate protein activity. p-Azophenylphenylalanine
(AzoPhe, 26) has been incorporated at Ile71 of the E. coli catabo-
lite activator protein, a transcriptional activator (Bose et al., 2006).
Its binding affinity for the promoter sequence decreases 4-fold
after irradiation at 334 nm, which converts the predominant trans
AzoPhe to the cis form. The isomerized cis AzoPhe is switched
back to the trans state by irradiation at > 420 nm, after which
the protein affinity for the promoter is completely recovered.
Generating New Protein Properties
Natural evolution affords numerous proteins for life needs,
whereas directed protein evolution and rational engineering
further increase the diversity of protein functions. Genetically
encoding additional functional groups into proteins has the
potential to generate totally novel and previously impossible
protein properties, and initial progress is encouraging.
Metal ions bound in proteins participate in a large number of
catalytic and electron transfer reactions in cells. Rationally332 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved
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predict and control the amino acid shells surrounding the metal
ion. Multidentate, metal-chelating amino acids with coordinating
atoms preorientated in the correct configuration may facilitate
such an effort. Bipyridylalanine (BpyAla, 27) has been shown to
reversibly bind copper ions when genetically incorporated into
the T4 lysozyme (Xie et al., 2007a). The Cu(II)-binding property
is exploited to oxidatively cleave the phosphosugar moiety of
the nucleic acid backbone.BpyAla is incorporated into the catab-
olite activator protein (CAP) at Lys26, a site close to the protein-
DNA interface (Lee and Schultz, 2008). In the presence of Cu(II)
and 3-mercaptopropionic acid, themutant CAP, originally a tran-
scription factor, cleaves double-stranded DNA at its consensus
sequence with high specificity. This method may be generally
applied to other DNA-binding proteins to map their preferred
DNA sequences.
The distance probe p-nitrophenylalanine (20) has recently
been rediscovered to stimulate potent immune responses for
novel immunogenic applications. An animal usually will not
mount a substantial immune response against a self-protein.
This immune self-tolerance has been shown to be broken by
introducing p-nitophenylalanine into the antigen (Gru¨newald
et al., 2008). Incorporation of this unnatural amino acid into
tumor necrosis factor a (TNF-a) leads to a strong immune
response directed at the unnatural mutant TNF-a in mice,
even in the absence of adjuvant. The generated antibodies
crossreact with native mouse TNF-a. The immune response is
Figure 7. Regulation of Protein Activity with
Photoresponsive Amino Acids
(A) Photocaged serine is used to control when the
target serine is regenerated and phosphorylated.
(B) The photoisomerizable p-azophenyl-phenylal-
anine is used to control the binding of CAP to its
promoter, which is determined by a gel mobility
shift assay.
retained in mice after exposure to
the mutant TNF-a, and it protects
mice against lipopolysaccharide-induced
death. These striking observations
have the potential for generating new
therapies for cancer or protein-misfolding
diseases.
Conclusions and Future
Perspectives
Since the first unnatural amino acid was
genetically encoded in live cells in 2001
(Wang et al., 2001), more than 40 unnat-
ural amino acids have been incorporated
into proteins in E. coli, and about a dozen
have been incorporated into yeast and
mammalian cells to date. It should be
noted that this method currently cannot
be used to incorporate unnatural amino
acids that are incompatible with the ribo-
some (such as D-amino acids and
b amino acids) or toxic to cells (such as
an analog that is structurally so similar
to a common amino acid that the analog is charged by the
cognate synthetase of the amino acid and misincorporated
into the proteome) (Hartman et al., 2007). The novel functional
groups embodied by these genetically encoded new amino
acids will enable an increasing number of new experiments for
biological research. The utility of many unnatural amino acids
has been demonstrated in proof-of-principle experiments, and
they are expected to be applied to various biological systems
for addressing challenging questions and uncovering unknowns
in the coming years. Unnatural amino acids that are fluorescent,
photoresponsive, bio-orthogonally reactive, or able to mimic
various protein modifications would be particularly useful in
addressing cell biology questions. Further improvement of the
unnatural amino acid incorporation efficiency and detailed
studies on the physiological effects of their incorporation would
be important for effective application, especially in mammalian
cells. The introduction of this technology into multicellular
organisms would open the field to biological problems concern-
ing how cells interact with one another in a variety of settings,
allowing aspects of development, neural connectivity, and
cellular signaling to be studied, to name only a few. The devel-
opment of random unnatural amino acid mutagenesis may
enable the evolution of protein properties that have never
existed in nature. Lastly, the genetic incorporation of unnatural
amino acids has implications on various aspects of the origin
and evolution of the genetic code itself, which remains to be
explored.Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 333
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